GW27-e0459 Attainment of acc/aha recommended ldl-c lowering with statin and ezetimibe+statin therapies

Peter P. Toth,Harold E. Bays,Michel Farnier,Erin Jensen,Joanne E. Tomassini,Adam B. Polis,JoAnne M. Foody,Andrew M. Tershakovec

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY（2016）

引用 0|浏览20

暂无评分

摘要

The ACC/AHA 2013 cholesterol guidelines do not specify lipid target levels, but rather treatment of patients classified by cardiovascular risk to achieve LDL-C reductions of ≥50% and ≥30 - u003c50% with high- and moderate-intensity statin therapy, respectively. This analysis evaluated the

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要